Patients have raised concerns over delays in treatment approvals, rejected medical claims and reduced allocations for essential cancer drugs and diagnostic tests.
The changes have reportedly left some patients unable to continue with scheduled chemotherapy sessions and other critical procedures as hospitals await authorisation from SHA.
At Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH), only 12 out of 30 oncology treatment requests submitted on Monday were approved, according to information obtained by the Daily Nation.
Even some patients whose requests were approved were reportedly required to make additional payments before accessing treatment.
The new approval process requires cancer treatment requests to pass through several checkpoints involving nurses, oncologists and pharmacists, raising concerns over delays for patients who need urgent medical attention.
However, Health Cabinet Secretary Aden Duale has defended the changes, insisting that the government has not reduced the amount allocated for cancer treatment under SHA.
Duale said the enhanced oncology benefit remains at Sh800,000 per patient, comprising Sh400,000 under the Social Health Insurance Fund and another Sh400,000 under the Emergency, Chronic and Critical Illness Fund.
He explained that the revised system is intended to standardise treatment costs, improve accountability and ensure patients receive appropriate care.
The government has also announced a new digital oncology system that will allow a single approval to cover multiple treatment cycles, tests and supportive medicines under an approved care plan.
Cancer patients and advocacy groups are, however, calling for urgent intervention to prevent administrative challenges from interrupting essential treatment.
Source

Leave a Reply